163 related articles for article (PubMed ID: 11812159)
1. The disputed role of COX-2 in myocardial infarction, is the jury still out?
Patel HH; Gross GJ
J Mol Cell Cardiol; 2002 Jan; 34(1):1-3. PubMed ID: 11812159
[No Abstract] [Full Text] [Related]
2. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications].
Bessa X; Piñol V; Elizalde JI; Castells A
Gastroenterol Hepatol; 2000 Dec; 23(10):483-90. PubMed ID: 11149225
[No Abstract] [Full Text] [Related]
3. [A heterogenous drug class. NSAID: classification and spectrum of action].
Ulbrich H; Dannhardt G
Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
[No Abstract] [Full Text] [Related]
4. The development of COX2 inhibitors.
Flower RJ
Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
[TBL] [Abstract][Full Text] [Related]
5. [Selective cyclooxygenase-2 (COX-2) inhibitors. Beliefs, reality and hope].
Brune K
Orthopade; 1997 Sep; 26(9):804-6; discussion 807. PubMed ID: 9432666
[No Abstract] [Full Text] [Related]
6. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
Steinhilber D
Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
[No Abstract] [Full Text] [Related]
7. Roles of COX-1 and COX-2.
McCormack K
J Rheumatol; 1998 Nov; 25(11):2279-81. PubMed ID: 9818678
[No Abstract] [Full Text] [Related]
8. COX in a crystal ball: current status and future promise of prostaglandin research.
FitzGerald GA; Loll P
J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
[No Abstract] [Full Text] [Related]
9. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
10. The cyclooxygenase-2 structure: new drugs for an old target?
Garavito RM
Nat Struct Biol; 1996 Nov; 3(11):897-901. PubMed ID: 8901861
[No Abstract] [Full Text] [Related]
11. The role of cyclooxygenase-2 in the pathogenesis of skin cancer.
Brecher AR
J Drugs Dermatol; 2002 Jul; 1(1):44-7. PubMed ID: 12847753
[TBL] [Abstract][Full Text] [Related]
12. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
[No Abstract] [Full Text] [Related]
13. [Significance of COX-2].
Tatsuguchi A; Sakamoto C
Nihon Rinsho; 2002 Feb; 60 Suppl 2():207-10. PubMed ID: 11979779
[No Abstract] [Full Text] [Related]
14. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
15. [Cyclooxy genase-2 and tumor progression].
Li GP; Yang T
Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):83-5. PubMed ID: 12778821
[No Abstract] [Full Text] [Related]
16. [Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
[No Abstract] [Full Text] [Related]
17. The molecular perspective: cyclooxygenase-2.
Goodsell DS
Stem Cells; 2000; 18(3):227-9. PubMed ID: 10840077
[No Abstract] [Full Text] [Related]
18. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
19. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
20. Prostaglandin endoperoxide H synthases-1 and -2.
Smith WL; Dewitt DL
Adv Immunol; 1996; 62():167-215. PubMed ID: 8781269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
